DGIdb - ESTRONE SODIUM SULFATE Drug Record

ESTRONE SODIUM SULFATE chembl:CHEMBL2106240

Alternate Names:

ESTRONE SODIUM SULFATE
MORESTIN
ENJUVIA
EVEX
CONESTORAL
17-OXOESTRA-1,3,5(10)-TRIEN-3-YL SODIUM SULFATE
CONJUGATED ESTROGEN
ESTROGENIC SUBSTANCES (CONJUGATED)
OESTRONE-3-SULPHATE SODIUM SALT
SODIUM ESTRONE 3-SULFATE
PREMARIN
ESTRONE-3-SULFATE SODIUM SALT
HYHORIN
ESTRONE SULFATE SODIUM
ESTROGENS
ESTROGENS, CONJUGATED
CENESTIN
CONJUGATED ESTROGENS
chembl:CHEMBL2106240
chemidplus:438-67-5
pubchem.compound:23667301
drugbank:00286

Drug Info:

(0 More Sources)

Publications:

Santamaría A et al., 2001, Risk of thrombosis associated with oral contraceptives of women from 97 families with inherited thrombophilia: high risk of thrombosis in carriers of the G20210A mutation of the prothrombin gene., Haematologica
Wu O et al., 2005, Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study., Thromb Haemost
Herrington DM et al., 2002, Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease., Arterioscler Thromb Vasc Biol
Oger E et al., 2003, Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial., Arterioscler Thromb Vasc Biol
Straczek C et al., 2005, Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration., Circulation
Andersen BS et al., 1998, Third generation oral contraceptives and heritable thrombophilia as risk factors of non-fatal venous thromboembolism., Thromb Haemost
Martinelli I et al., 1999, Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis., Arterioscler Thromb Vasc Biol
Cushman M et al., 2004, Estrogen plus progestin and risk of venous thrombosis., JAMA
Kemmeren JM et al., 2002, Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation., Thromb Haemost
Spannagl M et al., 2000, Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?, Eur J Contracept Reprod Health Care
Legnani C et al., 2002, Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use., Eur Heart J
Kemmeren JM et al., 2002, Effect of second- and third-generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutation., Blood Coagul Fibrinolysis
Kemmeren JM et al., 2004, Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial., Blood
Vandenbroucke JP et al., 1994, Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation., Lancet
Høibraaten E et al., 2001, Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial., Br J Haematol
Spink BC et al., 2000, SULT1A1 catalyzes 2-methoxyestradiol sulfonation in MCF-7 breast cancer cells., Carcinogenesis
Adjei AA et al., 2002, Catecholestrogen sulfation: possible role in carcinogenesis., Biochem Biophys Res Commun
Nishiyama T et al., 2002, Reverse geometrical selectivity in glucuronidation and sulfation of cis- and trans-4-hydroxytamoxifens by human liver UDP-glucuronosyltransferases and sulfotransferases., Biochem Pharmacol
Falany CN, 1997, Enzymology of human cytosolic sulfotransferases., FASEB J

ESTRONE SODIUM SULFATE F5

Interaction Score: 41.31

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
11532625 16113779 12067913 12869355 16301339 9459317 10073976 15467059 11859850 10943572 12069454 12138364 14551147 7968118 11703344

Sources:
PharmGKB
ESTRONE SODIUM SULFATE SULT1A1

Interaction Score: 23.67

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
11062153 11906176 12034366 9068609

Sources:
PharmGKB

PharmGKB: estrogens

Version: 18-August-2020

Alternate Names:

Drug Info:

Publications:

Santamaría A et al., 2001, Risk of thrombosis associated with oral contraceptives of women from 97 families with inherited thrombophilia: high risk of thrombosis in carriers of the G20210A mutation of the prothrombin gene., Haematologica

Wu O et al., 2005, Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study., Thromb Haemost

Herrington DM et al., 2002, Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease., Arterioscler Thromb Vasc Biol

ChemblDrugs: chembl:CHEMBL2106240
- Version: ChEMBL_27
Alternate Names:

Drug Info:

Publications:

ESTRONE SODIUM SULFATE Drug Record

ESTRONE SODIUM SULFATE chembl:CHEMBL2106240

Alternate Names:

Drug Info:

Publications:

ESTRONE SODIUM SULFATE F5

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 11532625 16113779 12067913 12869355 16301339 9459317 10073976 15467059 11859850 10943572 12069454 12138364 14551147 7968118 11703344

Sources: PharmGKB

ESTRONE SODIUM SULFATE SULT1A1

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 11062153 11906176 12034366 9068609

Sources: PharmGKB

PharmGKB: estrogens

Alternate Names:

Drug Info:

ChemblDrugs: chembl:CHEMBL2106240

Alternate Names:

Drug Info:

Publications:

Interaction Types & Directionality:

n/a

PMIDs:
11532625 16113779 12067913 12869355 16301339 9459317 10073976 15467059 11859850 10943572 12069454 12138364 14551147 7968118 11703344

Sources:
PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
11062153 11906176 12034366 9068609

Sources:
PharmGKB